No Data
No Data
Express News | 'FDA Won't Take Action Against GLP-1 Compounders As It Rethinks Tirzepatide Shortage' - Endpoints News
European Equities Close Mostly Higher in Friday Trading; Novo Nordisk's Catalent Acquisition Faces Roadblock
Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?
Novo Nordisk Says European Medicines Agency Recommends Approval of Hemophilia Treatment
Express News | The European Medicines Agency's Committee For Medicinal Products For Human Use Has Adopted A Positive Opinion, Recommending Approval Of Novo Nordisk's Alhemo (Concizumab) As The First Once-Daily Subcutaneous Prophylactic Treatment For People Aged 12...
Consumer, Labor Groups Urge FTC to Block Catalent Sale to Novo Nordisk - Report
No Data
No Data
The Bunny Trader : nuclear energy :
Bull X Bear OP The Bunny Trader : I will add them Nuclear as well